Burnham Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Burnham Asset Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$310K	Buy	+2,130	New	+$302K	0.09%	163

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Burnham Asset Management's TARO Position: Q2 2016 in Review

Burnham Asset Management opened a new position in Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2016: 2,130 shares worth $310K. The stake represents 0.09% of the portfolio and ranks #163 among its holdings.

159 funds tracked by Wall St. Rank hold TARO as of Q2 2016.

Burnham Asset Management held 2,130 shares of Taro Pharmaceutical Industries Ltd. worth $310K as of Q2 2016.
Taro Pharmaceutical Industries Ltd. was a new Burnham Asset Management position in Q2 2016.
Taro Pharmaceutical Industries Ltd. made up 0.09% of Burnham Asset Management's portfolio in Q2 2016, its #163 holding.
159 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2016.

Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.